AXIM Completes Pre-Clinical Drug Studies on Compound...
AXIM Biotechnologies, Inc., an international healthcare solutions company targeting oncological and cannabinoid research, announced that its subsidiary Sapphire Biotech, Inc. has completed pre-clinical drug...
March 25, 2020
6:00 am By Neha Mule